Statistics The Student’s t-test was used for comparisons between two groups and analysis of variance using Sigma Stat software was used for statistical differences between multiple groups. P,0.05 was considered statistically significant. Acknowledgments We would like to thank Cathy Alford at the Department of Veterans affairs for help with the flow cytometric analysis and Glenda Mernaugh for References 1. Verrey F, Jack DL, Paulsen IT, Saier MH, Pfeiffer R (1999) New glycoprotein- associated amino acid transporters. J Membr Biol 172: 181–192. 2. Verrey F, Meier C, Rossier G, Kuhn LC (2000) Glycoprotein-associated amino acid exchangers: broadening the range of transport specificity. Pflugers Arch 440: 503–512. 3. Wells RG, Lee WS, Kanai Y, Leiden JM, Hediger MA (1992) The 4F2 antigen heavy chain induces uptake of neutral and dibasic amino acids in Xenopus oocytes. J Biol Chem 267: 15285–15288. 4. Bertran J, Werner A, Moore ML, Stange G, Markovich D, et al. (1992) Expression cloning of a cDNA from rabbit kidney cortex that induces a single transport system for cystine and dibasic and neutral amino acids. Proc Natl Acad Sci U S A 89: 5601–5605. 5. Quackenbush E, Clabby M, Gottesdiener KM, Barbosa J, Jones NH, et al. (1987) Molecular cloning of complementary DNAs encoding the heavy chain of the human 4F2 cell-surface antigen: a type II membrane glycoprotein involved in normal and neoplastic cell growth [published erratum appears in Proc Natl Acad Sci U S A 1987 Dec; 84(23): 8618]. ProcNatlAcadSciUSA 84: 6526–6530. 6. Tsumura H, Suzuki N, Saito H, Kawano M, Otake S, et al. (2003) The targeted disruption of the CD98 gene results in embryonic lethality. Biochem Biophys Res Commun 308: 847–851. 7. Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, et al. (1998) Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen. JBiolChem 273: 23629– 23632. 8. Mastroberardino L, Spindler B, Pfeiffer R, Loffing J, Skelley PJ, et al. (1998) Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family. Nature 395: 288–291. 9. Pfeiffer R, Rossier G, Spindler B, Meier C, Kuhn L, et al. (1999) Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family. EMBO J 18: 49–57. 10. Prasad PD, Wang H, Huang W, Kekuda R, Rajan DP, et al. (1999) Human LAT1, a subunit of system L amino acid transporter: molecular cloning and transport function. Biochem Biophys Res Commun 255: 283–288. 11. Segawa H, Fukasawa Y, Miyamoto K, Takeda E, Endou H, et al. (1999) Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem 274: 19745– 19751. 12. Fukasawa Y, Segawa H, Kim JY, Chairoungdua A, Kim DK, et al. (2000) Identification and characterization of a Na(+)-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids. J Biol Chem 275: 9690–9698. 13. Bassi MT, Gasol E, Manzoni M, Pineda M, Riboni M, et al. (2001) Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc. Pflugers Arch 442: 286–296. 14. Pineda M, Fernandez E, Torrents D, Estevez R, Lopez C, et al. (1999) Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. J Biol Chem 274: 19738–19744. 15. Rossier G, Meier C, Bauch C, Summa V, Sordat B, et al. (1999) LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine. J Biol Chem 274: 34948–34954. 16. Chairoungdua A, Kanai Y, Matsuo H, Inatomi J, Kim DK, et al. (2001) Identification and characterization of a novel member of the heterodimeric amino acid transporter family presumed to be associated with an unknown heavy chain. J Biol Chem 276: 49390–49399. 17. Fenczik CA, Zent R, Dellos M, Calderwood DA, Satriano J, et al. (2001) Distinct domains of CD98hc regulate integrins and amino acid transport. J Biol Chem 276: 8746–8752. 18. Henderson NC, Collis EA, Mackinnon AC, Simpson KJ, Haslett C, et al. (2004) CD98hc (SLC3A2) interaction with beta 1 integrins is required for transforma- tion. J Biol Chem 279: 54731–54741. 19. Zent R, Fenczik CA, Calderwood DA, Liu S, Dellos M, et al. (2000) Class- and splice variant-specific association of CD98 with integrin beta cytoplasmic domains. J Biol Chem 275: 5059–5064. 20. Fenczik CA, Sethi T, Ramos JW, Hughes PE, Ginsberg MH (1997) Complementation of dominant suppression implicates CD98 in integrin activation. Nature 370: 81–85. CD98 Regulates Proliferation by Activating MAPKs technical assistance. We would like to thank Dr. Mark H. Ginsberg for making the CD98fl/fl mice available to us. Author Contributions Conceived and designed the experiments: NB AP RZ. Performed the experiments: NB CF AP RZ. Analyzed the data: NB CF AP RZ. Contributed reagents/materials/analysis tools: NB CF AP RZ. Wrote the paper: NB AP RZ. 21. Merlin D, Sitaraman S, Liu X, Eastburn K, Sun J, et al. (2001) CD98-mediated links between amino acid transport and b1 integrin distribution in polarized columnar epithelia. J Biol Chem 15: 15. 22. Kolesnikova TV, Mannion BA, Berditchevski F, Hemler ME (2001) beta1 integrins show specific association with CD98 protein in low density membranes. BMC Biochem 2: 10. 23. Feral CC, Nishiya N, Fenczik CA, Stuhlmann H, Slepak M, et al. (2005) CD98hc (SLC3A2) mediates integrin signaling. Proc Natl Acad Sci U S A 102: 355–360. 24. Feral CC, Zijlstra A, Tkachenko E, Prager G, Gardel ML, et al. (2007) CD98hc (SLC3A2) participates in fibronectin matrix assembly by mediating integrin signaling. J Cell Biol 178: 701–711. 25. Prager GW, Feral CC, Kim C, Han J, Ginsberg MH (2007) CD98hc (SLC3A2) interaction with the integrin beta subunit cytoplasmic domain mediates adhesive signaling. J Biol Chem 282: 24477–24484. 26. Cai S, Bulus N, Fonseca-Siesser PM, Chen D, Hanks SK, et al. (2005) CD98 modulates integrin beta1 function in polarized epithelial cells. J Cell Sci 118: 889–899. 27. Cantor J, Browne CD, Ruppert R, Feral CC, Fassler R, et al. (2009) CD98hc facilitates B cell proliferation and adaptive humoral immunity. Nature immunology 10: 412–419. 28. Cantor J, Slepak M, Ege N, Chang JT, Ginsberg MH (2011) Loss of T cell CD98 H chain specifically ablates T cell clonal expansion and protects from autoimmunity. Journal of immunology 187: 851–860. 29. Fogelstrand P, Feral CC, Zargham R, Ginsberg MH (2009) Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2). The Journal of experimental medicine 206: 2397–2406. 30. Nguyen HT, Dalmasso G, Torkvist L, Halfvarson J, Yan Y, et al. (2011) CD98 expression modulates intestinal homeostasis, inflammation, and colitis-associated cancer in mice. The Journal of clinical investigation 121: 1733–1747. 31. Ganapathy V, Thangaraju M, Prasad PD (2009) Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacology & therapeutics 121: 29–40. 32. Tomiya T, Omata M, Fujiwara K (2004) Branched-chain amino acids, hepatocyte growth factor and protein production in the liver. Hepatology research : the official journal of the Japan Society of Hepatology 30S: 14–18. 33. Wagner CA, Lang F, Broer S (2001) Function and structure of heterodimeric amino acid transporters. Am J Physiol Cell Physiol 281: C1077–1093. 34. Hara K, Kudoh H, Enomoto T, Hashimoto Y, Masuko T (2000) Enhanced tumorigenicity caused by truncation of the extracellular domain of GP125/ CD98 heavy chain. Oncogene 19: 6209–6215. 35. Cantor JM, Ginsberg MH, Rose DM (2008) Integrin-associated proteins as potential therapeutic targets. Immunological reviews 223: 236–251. 36. Torrents D, Estevez R, Pineda M, Fernandez E, Lloberas J, et al. (1998) Identification and characterization of a membrane protein (y+L amino acid transporter) that associates with 4F2hc to encode the amino acid transport activity y+L. JBiolChem 273: 32437–32445. 37. Zhang X, Mernaugh G, Yang DH, Gewin L, Srichai MB, et al. (2009) beta1 integrin is necessary for ureteric bud branching morphogenesis and maintenance of collecting duct structural integrity. Development 136: 3357–3366. 38. Sato Y, Heimeier RA, Li C, Deng C, Shi YB (2011) Extracellular domain of CD98hc is required for early murine development. Cell & bioscience 1: 7. 39. Chrostowski MK, McGonnigal BG, Stabila JP, Padbury JF (2010) Role of the L- amino acid transporter-1 (LAT-1) in mouse trophoblast cell invasion. Placenta 31: 528–534. 40. Yanagida O, Kanai Y, Chairoungdua A, Kim DK, Segawa H, et al. (2001) Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochimica et biophysica acta 1514: 291–302. 41. Tato I, Bartrons R, Ventura F, Rosa JL (2011) Amino acids activate mammalian target of rapamycin complex 2 (mTORC2) via PI3K/Akt signaling. The Journal of biological chemistry 286: 6128–6142. 42. Ye J, Kumanova M, Hart LS, Sloane K, Zhang H, et al. (2010) The GCN2- ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. The EMBO journal 29: 2082–2096. 43. Kilberg MS, Pan YX, Chen H, Leung-Pineda V (2005) Nutritional control of gene expression: how mammalian cells respond to amino acid limitation. Annual review of nutrition 25: 59–85. PLoS ONE | www.plosone.org 11 June 2012 | Volume 7 | Issue 6 | e40026